Showing results (91-100 of 171) with videos related to
Sort By:
Pageof 18
Systematic Reviews|January 25, 2024
Effectiveness of gold nanoparticles in prevention and treatment of oral mucositis in animal models: a systematic reviewMinati Choudhury, Paul Brunton, Donald Schwass, et al.STAR Protocols|December 21, 2025
Protocol for a murine skin abscess model to study bacterial infection dynamics, microbial interactions, and treatment efficacyAnupriya Gupta, Kathleen J Sircombe, Janaya D Stevenson, et al.Pharmaceutical Research|June 15, 2012
Powder strength distributions for understanding de-agglomeration of lactose powdersShyamal C Das, Srinivas Ravindra Babu Behara, Jurgen B Bulitta, et al.Journal of Breath Research|March 1, 2013
Quantification of hydrogen cyanide (HCN) in breath using selected ion flow tube mass spectrometry--HCN is not a biomarker of Pseudomonas in chronic suppurative lung diseaseJack Dummer, Malina Storer, Sharon Sturney, et al.Analytical Biochemistry|December 13, 2024
Comparative lipidomics profiles of planktonic and biofilms of methicillin-resistant and -susceptible Staphylococcus aureusShilpa Saseendran Nair, Torsten Kleffmann, Briana Smith, et al.Journal of Medicinal Chemistry|May 23, 2024
Site-Specific Antimicrobial Activity of a Dual-Responsive Ciprofloxacin ProdrugCatherine L Ross, Aggie Lawer, Kathleen J Sircombe, et al.International Journal of Pharmaceutics|February 1, 2025
Inhalable spray-dried dry powders combining ivermectin and niclosamide to inhibit SARS-CoV-2 infection in vitroCatherine Su, Tushar Saha, Shubhra Sinha, et al.Frontiers in Microbiology|May 21, 2020
NtrBC Regulates Invasiveness and Virulence of Pseudomonas aeruginosa During High-Density InfectionMorgan A Alford, Arjun Baghela, Amy T Y Yeung, et al.European Biophysics Journal : EBJ|January 22, 2021
Towards understanding single-channel characteristics of OccK8 purified from Pseudomonas aeruginosaFatma Dogan Guzel, Daniel Pletzer, Araz Norouz Dizaji, et al.Journal of Internal Medicine|July 21, 2021
Dual versus single long-acting bronchodilator use could raise acute coronary syndrome risk by over 50%: A population-based nested case-control studyLianne Parkin, Sheila Williams, Katrina Sharples, et al.Pageof 18